Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression

AIMS/HYPOTHESIS: The thiazolidinedione (TZD) rosiglitazone is a peroxisome proliferator-activated receptor-γ agonist that induces adipocyte differentiation and, hence, lipid accumulation. This is in apparent contrast to the long-term glucose-lowering, insulin-sensitising effect of rosiglitazone. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, P., Renes, J., Bouwman, F., Bunschoten, A., Mariman, E., Keijer, J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914285/
https://www.ncbi.nlm.nih.gov/pubmed/17245590
http://dx.doi.org/10.1007/s00125-006-0565-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914285/
https://www.ncbi.nlm.nih.gov/pubmed/17245590
http://dx.doi.org/10.1007/s00125-006-0565-0

Ejemplares similares